製品ポートフォリオ

    image
    image
    a
    b
    c
    d
    e
    f
    g
    h
    i
    j
    k
    l
    m
    n
    o
    p
    q
    r
    s
    t
    u
    v
    w
    x
    y
    z
    Acenocumarol*
    Acenocumarol*
    EU DMF:
    CAS No.
    152-72-7
    Acetazolamide
    Acetazolamide
    EU DMF:US DMF No.: 10383CEP:
    多形体 CAS No.
    Form II 59-66-5
    Alendronate sodium
    Alendronate sodium
    EU DMF:US DMF No.: 16962CEP:
    多形体 CAS No. Other Documentation Other Information
    Trihydrate 121268-17-5 Japanese DMF Trihydrate
    Aniracetam
    Aniracetam
    EU DMF:
    多形体 CAS No.
    Monoclinic form 72432-10-1
    Aripiprazole
    Aripiprazole
    EU DMF:US DMF No.: 23314CEP:
    多形体 CAS No.
    Type I 129722-12-9
    Avanafil
    Avanafil
    EU DMF:US DMF No.: 29689
    多形体 CAS No.
    Crystalline, none 330784-47-9
    Baclofen
    Baclofen
    EU DMF:US DMF No.: 18014CEP:
    多形体 CAS No. Other Documentation
    Form B 1134-47-0 Japanese DMF
    Carbamazepine
    Carbamazepine
    EU DMF:US DMF No.: 26266CEP:
    多形体 CAS No.
    Form III 298-46-4
    Carvedilol
    Carvedilol
    EU DMF:US DMF No.: 17060CEP:
    多形体 CAS No.
    Form II 72956-09-3
    Carvedilol phosphate hemihydrate
    Carvedilol phosphate hemihydrate
    EU DMF:US DMF No.: 20633
    多形体 CAS No.
    Form I 610309-89-2
    Clopamide*
    Clopamide*
    EU DMF:
    CAS No.
    636-54-4
    Cyclobenzaprine hydrochloride
    Cyclobenzaprine hydrochloride
    EU DMF:US DMF No.: 18317
    多形体 CAS No.
    Crystalline, none 6202-23-9
    Etodolac
    Etodolac
    EU DMF:US DMF No.: 11405CEP:
    多形体 CAS No. Other Documentation
    Crystalline racemate, none 41340-25-4 Japanese DMF
    Hydrochlorothiazide
    Hydrochlorothiazide
    EU DMF:US DMF No.: 17599CEP:
    多形体 CAS No. Other Documentation
    Form I 58-93-5 Japanese DMF
    Ibandronate sodium
    Ibandronate sodium
    EU DMF:US DMF No.: 25638
    多形体 CAS No. Other Documentation Other Information
    Monohydrate 138926-19-9 Chinese DMF - under registration Monohydrate
    Lamotrigine
    Lamotrigine
    EU DMF:US DMF No.: 20548CEP:
    多形体 CAS No. Other Documentation
    Anhydrous monoclinic 84057-84-1 Chinese DMF - under registration
    Magnesium aspartate
    Magnesium aspartate
    EU DMF:
    多形体 CAS No.
    Amorphous 28184-71-6
    Metronidazole
    Metronidazole
    EU DMF:US DMF No.: 9294
    多形体 CAS No.
    Monoclinic crystal system with space group P21/c 443-48-1
    Opipramol dihydrochloride
    Opipramol dihydrochloride
    EU DMF:
    多形体 CAS No. Other Information
    Amorphous 909-39-7 Amorphous
    Pentoxifylline
    Pentoxifylline
    EU DMF:US DMF No.: 20976CEP:
    多形体 CAS No. Other Documentation
    Form I 1677687 Chinese DMF - under registration
    Phenyl salicylate
    Phenyl salicylate
    EU DMF:
    多形体 CAS No.
    Crystalline orthorhombic form 118-55-8
    Piracetam
    Piracetam
    EU DMF:CEP:
    多形体 CAS No.
    Form II 7491-74-9
    Prasugrel hydrochloride
    Prasugrel hydrochloride
    EU DMF:US DMF No.: 30765
    多形体 CAS No.
    Form B2 389574-19-0
    Prasugrel maleate
    Prasugrel maleate
    EU DMF:US DMF No.: 30764
    多形体 CAS No.
    Form I 1373350-60-7
    Repaglinide
    Repaglinide
    EU DMF:US DMF No.: 21149CEP:
    多形体 CAS No.
    Form I 135062-02-1
    Risedronate sodium
    Risedronate sodium
    EU DMF:US DMF No.: 20384CEP:
    多形体 CAS No. Other Documentation
    Form A 115436-72-1 Japanese DMF
    Salicylamide
    Salicylamide
    EU DMF:
    多形体 CAS No.
    Monoclinic form (space group I2/a) 65-45-2
    Sildenafil base
    Sildenafil base
    EU DMF:US DMF No.: 28319
    CAS No.
    139755-83-2
    Sildenafil citrate
    Sildenafil citrate
    EU DMF:US DMF No.: 23930CEP:
    多形体 CAS No. Other Documentation Other Information
    Anhydrous Form 171599-83-0 Japanese DMF / Chinese DMF Anhydrous
    Sodium salicylate
    Sodium salicylate
    EU DMF:US DMF No.: 26873
    多形体 CAS No.
    Monoclinic form (space group P21/m) 54-21-7
    Tolterodine tartrate
    Tolterodine tartrate
    EU DMF:US DMF No.: 24345CEP:
    多形体 CAS No.
    Form I 124937-52-6
    Topiramate
    Topiramate
    EU DMF:US DMF No.: 20581
    多形体 CAS No.
    Orthorhombic structure 97240-79-4
    Xylometazoline HCl*
    Xylometazoline HCl*
    EU DMF:CEP: under registration
    CAS No.
    1218-35-5
    Zoledronic acid
    Zoledronic acid
    EU DMF:US DMF No.: 24306
    多形体 CAS No. Other Documentation Other Information
    Monohydrate 165800-06-6 Japanese DMF Monohydrate

    見積もり依頼・詳細情報

    * 必須項目

    * COA依頼

    * 必須項目

    * * Polfa Warsaw API Manufacturing Site

    PDF - PRODUCT LIST PDF - PIPELINE

    免責事項

    有効特許によって保護されている製品は、そのような製品の販売が特許侵害となる国では販売対象となりません。輸入国における製品の特許状況の確認は購入者の責任に含まれます。ポーランド国内において有効特許によって保護されている製品は、承認申請のみを目的として開発されたものです。

    API Polpharma パイプライン

    後期段階

     ProductTherapeutic Area
    1 Avanafil* 男性機能
    勃起不全
    2 Cabazitaxel 腫瘍学-前立腺癌
    3 Dabigatran etexilate 心臓血管系
    抗凝血薬
    4 Darifenacin hydrobromide 泌尿器学
    5 Linagliptin 糖尿病治療 –2型糖尿病
    6 Rivaroxaban 循環器系
    抗凝血薬
    7 Saxagliptin monohydrate base 糖尿病治療 - 2型糖尿病
    8 Tadalafil 男性機能
    勃起不全/性的不全治療
    9 Ticagrelor 抗凝血薬
    10 Vardenafil hydrochloride 男性機能
    勃起不全

    * ポーランド国内において化合物特許のない製品

    免責事項

    上記リストは情報提供のみを目的として提示されており、正式なオファーを構成するものではありません。ポーランド国内および他国において有効特許によって保護されている(SPS)製品は、該当する知的所有権(IP)の有効期間が終了されない限り、販売提供されることはありません。

    文書による検索

    製品名 治療領域 多形体 CAS No. US DMF No.
    Acenocumarol* Cardiovascular/Hypertension 152-72-7
    Acetazolamide Cardiovascular/Hypertension Form II 59-66-5 10383
    Alendronate sodium Musculo-skeletal diseases Trihydrate 121268-17-5 16962
    Aniracetam CNS Monoclinic form 72432-10-1
    Aripiprazole CNS Type I 129722-12-9 23314
    Avanafil Men's Health Crystalline, none 330784-47-9 29689
    Baclofen Musculo-skeletal diseases Form B 1134-47-0 18014
    Carbamazepine CNS Form III 298-46-4 26266
    Carvedilol Cardiovascular/Hypertension Form II 72956-09-3 17060
    Carvedilol phosphate hemihydrate Cardiovascular/Hypertension Form I 610309-89-2 20633
    Clopamide* Cardiovascular/Hypertension 636-54-4
    Cyclobenzaprine hydrochloride Musculo-skeletal diseases Crystalline, none 6202-23-9 18317
    Etodolac Analgesic/Inflammation Crystalline racemate, none 41340-25-4 11405
    Hydrochlorothiazide Cardiovascular/Hypertension Form I 58-93-5 17599
    Ibandronate sodium** Musculo-skeletal diseases Monohydrate 138926-19-9 25638
    Lamotrigine** CNS Anhydrous monoclinic 84057-84-1 20548
    Magnesium aspartate Musculo-skeletal diseases Amorphous 28184-71-6
    Metronidazole Analgesic/Inflammation Monoclinic crystal system with space group P21/c 443-48-1 9294
    Nefopam HCl*Analgesic/Inflammation23327-57-3
    Opipramol dihydrochloride CNS Amorphous 909-39-7
    Pentoxifylline** Cardiovascular/Hypertension Form I 1677687 20976
    Phenyl salicylate Analgesic/Inflammation Crystalline orthorhombic form 118-55-8
    Piracetam CNS Form II 7491-74-9
    Prasugrel hydrochloride Cardiovascular/Hypertension Form B2 389574-19-0
    Prasugrel maleate Cardiovascular/Hypertension Form 1 1373350-60-7
    Repaglinide Metabolics Form I 135062-02-1 21149
    Risedronate sodium Musculo-skeletal diseases Form A 329003-65-8 20384
    Salicylamide Analgesic/Inflammation Monoclinic form (space group I2/a) 65-45-2
    Sildenafil base Men's Health 139755-83-2 28319
    Sildenafil citrate Men's Health Anhydrous Form 171599-83-0 23930
    Sodium salicylate Analgesic/Inflammation Monoclinic form (space group P21/m) 54-21-7 26873
    Tolterodine tartrate Urology Form 1 124937-52-6 24345
    Topiramate CNS Orthorhombic structure 97240-79-4 20581
    Xylometazoline HCl* Analgesic/Inflammation 1218-35-5
    Zoledronic acid Musculo-skeletal diseases Monohydrate 165800-06-6 24306

    * Polfa Warsaw API Manufacturing Site

    ** Under registration